Table 7.
Treatment; sample number (n) | Control; sample number (n) | Total clinical effect rate | Model used | Therapeutic effects and actions | Refs. |
---|---|---|---|---|---|
Proprietary CHM enema decoction; n = 30 | Oral Sanjie analgesic capsules; n = 30 | Human study | CA-125↓, VEGF↓ | [100] | |
CHM enema; n = 47 | Mifepristone; n = 36 | T: 89.4% vs. 78.7% | Human study | Pain score↓, recurrence rate↓ | [101] |
CHM enema, Dihuang Jisheng decoction; n = 46 | Mifepristone; n = 46 | T: 91.30% vs. 73.91% | Human study | E2↓, FSH↓, LH↓ | [103] |
CHM ointments; n = 36 | Danazol; n = 36 | T: 94.40% vs. 77.80% | Human study | [107] | |
CHM enema combined with patch therapy; n = 32 | Ibuprofen sustained-release capsules; n = 32 | Human study | VAS score↓ | [110] |
Note: T (total effect rate) = number of effective cases/total number of cases; effective case refers to the patients or animal models whose signs and symptoms were improved after treatment.